Portia P Williams
Overview
Explore the profile of Portia P Williams including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tenover F, Williams P, Stocker S, Thompson A, Clark L, Limbago B, et al.
J Clin Microbiol
. 2007 Jul;
45(9):2917-22.
PMID: 17634301
A challenge panel of enterococci (n = 50) and staphylococci (n = 50), including 17 and 15 isolates that were nonsusceptible to linezolid, respectively, were tested with the Clinical and...
2.
Stone N, OHara C, Williams P, McGowan Jr J, Tenover F
J Clin Microbiol
. 2006 Dec;
45(2):340-6.
PMID: 17135429
We compared the antimicrobial susceptibility testing results generated by disk diffusion and the VITEK 2 automated system with the results of the Clinical and Laboratory Standards Institute (CLSI) broth microdilution...
3.
Tenover F, Kalsi R, Williams P, Carey R, Stocker S, Lonsway D, et al.
Emerg Infect Dis
. 2006 Sep;
12(8):1209-13.
PMID: 16965699
Detecting beta-lactamase-mediated carbapenem resistance among Klebsiella pneumoniae isolates and other Enterobacteriaceae is an emerging problem. In this study, 15 blaKPC-positive Klebsiella pneumoniae that showed discrepant results for imipenem and meropenem...
4.
Steward C, Raney P, Morrell A, Williams P, McDougal L, Jevitt L, et al.
J Clin Microbiol
. 2005 Apr;
43(4):1716-21.
PMID: 15814990
Disk diffusion and broth microdilution (BMD) were used to perform clindamycin (CLI) induction testing on 128 selected nonduplicate isolates of Staphylococcus aureus. Disk diffusion testing involved placing CLI and erythromycin...
5.
Jevitt L, Smith A, Williams P, Raney P, McGowan Jr J, Tenover F
Microb Drug Resist
. 2004 Mar;
9(4):389-93.
PMID: 15000746
We assessed the in vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin (QD) against a contemporary challenge panel of 88 staphylococcal and 90 enterococcal isolates. The staphylococci selected included vancomycin-intermediate Staphylococcus...
6.
Tenover F, Raney P, Williams P, Rasheed J, Biddle J, Oliver A, et al.
J Clin Microbiol
. 2003 Jul;
41(7):3142-6.
PMID: 12843054
To determine whether confirmatory tests for extended-spectrum beta-lactamase (ESBL) production in Escherichia coli are necessary, we selected 131 E. coli isolates that met the National Committee for Clinical Laboratory Standards...
7.
Steward C, Mohammed J, Swenson J, Stocker S, Williams P, Gaynes R, et al.
J Clin Microbiol
. 2003 Jan;
41(1):351-8.
PMID: 12517872
From January 1996 to May 1999, Project ICARE (Intensive Care Antimicrobial Resistance Epidemiology) received 448 nonduplicate clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa that were reported to be imipenem intermediate...